옵션 체인은 다양한 행사가격과 만기일에 대한 EuroDry의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 EuroDry에 대한 시장 심리를 평가합니다..

EuroDry (NASDAQ:EDRY) 주식, 옵션 체인

EuroDry

EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.

EuroDry Ltd

Morgan Stanley analyst Angel Castillo maintains Donaldson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DCI#NYSE">DCI</a>) with a Underweight and raises the price target from $65 to $69.

News

Price Target

Analyst Ratings

Morgan Stanley Maintains Underweight on Donaldson, Raises Price Target to $69

Morgan Stanley analyst Josh Baer maintains Docusign (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) with a Equal-Weight and lowers the price target from $92 to $86.

DOCU

Morgan Stanley Maintains Equal-Weight on Docusign, Lowers Price Target to $86

Stablecoin issuer Circle Internet Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) shares are climbing again Friday after the stock soared on its first day of trading on Thursday. The stock opened at around $69 and soared as high as $100 during the session, closing at $83.23, for a 168% gain <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45800399/circle-surges-to-69-in-nyse-debut-raising-1-1b-as-investors-bet-on-stablecoins-going-mainstream">from the IPO price. </a>
What To Know: Cathie Wood's ARK Invest scooped up 4.49 million shares worth over $373 million spread across ARK's Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#BATS">ARKK</a>), Next Generation Internet ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#BATS">ARKW</a>) and Fintech Innovation ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#BATS">ARKF</a>). 
Read Next: <a href="https://www.benzinga.com/news/politics/25/06/45795080/whatever-you-think-of-elon-musk-you-must-support-his-fight-against-the-big-beautiful-bill-says-black-swan-author-nassim-taleb?utm_source=articleShare">&#8216;Whatever You Think Of Elon Musk, You Must Support His Fight Against The Big Beautiful Bill,&#8217; Says &#8216;Black Swan&#8217; Author Nassim Taleb</a>&nbsp;
The acquisition<a href="https://www.benzinga.com/markets/equities/25/06/45807132/cathie-wood-drops-373-million-on-circles-168-rally-dumps-coinbase-and-crypto-holdings-is-ark-ditching-bitcoin-for-stablecoins"> could point to</a> Ark&#8217;s bullish outlook on the stablecoin sector, as Circle positions itself at the forefront of digital payments and blockchain innovation.&nbsp;
On Thursday evening, Wood highlighted Circle&#8217;s IPO in a <a href="https://x.com/CathieDWood/status/1930814829507539121">post on X</a>, calling it an "&#8221;amazing debut."&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">On the day of the amazing debut of <a href="https://twitter.com/search?q=%24CRCL&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$CRCL</a>, <a href="https://twitter.com/LorenzoARK?ref_src=twsrc%5Etfw">@LorenzoARK</a>'s stablecoin blog is timely. USDC and Tether are creating demand for dollars, helping to offset the declining demand for dollars from China and other countries. <a href="https://t.co/oMepBYZ4km">https://t.co/oMepBYZ4km</a>
&mdash; Cathie Wood (@CathieDWood) <a href="https://twitter.com/CathieDWood/status/1930814829507539121?ref_src=twsrc%5Etfw">June 6, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Wood also pointed to a <a href="https://www.ark-invest.com/articles/analyst-research/stablecoins-as-a-us-financial-ally">blog post</a> written by ARK Invest anlayst Lorenzo Valente stating that stablecoins like USDC and Tether are creating significant demand for U.S. dollars, helping to counterbalance declining dollar demand from countries such as China.&nbsp;
As of early 2025, Circle held over $22 billion in U.S. Treasuries, making it one of the largest non-sovereign holders of U.S. government debt.&nbsp;
Tether and Circle combined hold more than $166 billion in U.S. Treasuries, a sum that would place them among the top foreign holders of U.S. debt—surpassing Germany and trailing only major holders such as China, Japan and the UK.&nbsp;
CRCL Price Action: Circle shares were up 34.5% at $111.97&nbsp;at the time of publication Friday, according to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>.&nbsp;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/space/25/06/45724938/space-stocks-weekly-countdown-rocketlab-gets-analyst-love-while-virgin-galactic-slides-into-june?utm_source=articleShare">Space Stocks Weekly Countdown: RocketLab Gets Analyst Love While Virgin Galactic Slides Into June</a></li>
</ul>
Photo: Shutterstock

Equities

IPOs

Movers

Tech

ARKF

ARKK

ARKW

CRCL

Cathie Wood Calls Circle's IPO An 'Amazing Debut'

Loop Capital analyst Anthony Chukumba maintains Five Below (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FIVE#NASDAQ">FIVE</a>) with a Hold and raises the price target from $90 to $130.

FIVE

Loop Capital Maintains Hold on Five Below, Raises Price Target to $130

Morgan Stanley analyst Meta Marshall maintains Ciena (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIEN#NYSE">CIEN</a>) with a Equal-Weight and raises the price target from $44 to $73.

CIEN

Morgan Stanley Maintains Equal-Weight on Ciena, Raises Price Target to $73

While investors search for stable income in the volatile market, NEOS Investments brings its next innovation: the NEOS Gold High Income ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/IAUI#BATS">IAUI</a>). The <a href="https://www.benzinga.com/etfs">new fund</a> is unique in merging physical gold exposure with an innovative options strategy aimed at producing high monthly income, a timely release considering the increasing demand for stable yield from safe-haven assets.
IAUI's strategy combines up to 25% holdings in physically backed gold ETPs (exchange traded products) with a synthetic options approach that buys calls and sells puts on gold ETPs. This dual method allows the fund to closely track gold prices while producing income. Adding to the yield, IAUI also sells covered calls on gold ETPs as reference assets, converting capped upside into consistent income.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/06/45816242/fidelitys-new-futures-etf-offers-investors-a-new-way-to-hedge-risks">Fidelity&#8217;s New Futures ETF Offers Investors A New Way To Hedge Risks</a>
Gold&#8217;s performance this year has mirrored increasing global economic anxiety. After reaching an all-time <a href="https://tradingeconomics.com/commodity/gold#:~:text=Gold%20increased%20729.61%20USD%2Ft,3500%20in%20April%20of%202025.">high </a>of $3,500 per ounce in April, prices recently rallied amid new trade tensions and other economic factors. With the U.S. dollar weakening and volatility remaining elevated, gold continues to be a preferred safe haven, and IAUI provides a new means of gaining exposure while offering improved income potential.
IAUI also invests in government securities as collateral, achieving growth and safety with active management to control risk and capture gains.
The launch of the new ETF broadens NEOS&#8217;s increasing alternatives portfolio, which also features high-income Bitcoin and real estate holdings. With an expense ratio of 0.78%, IAUI offers an appealing option for income-focused investors wishing to diversify from conventional bonds and shares.
As demand for safe havens strengthens, the NEOS Gold High Income ETF is likely to rapidly rise to become a popular vehicle for investors wanting both gold&#8217;s security and increased income flows.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45804512/trump-musk-feud-gets-ugly-etfs-exposed-with-tesla-caught-in-the-crossfire">Trump-Musk Feud Gets Ugly: ETFs Exposed With Tesla Caught In The Crossfire</a></li>
</ul>
Photo by FOTOGRIN via Shutterstock

New ETFs

Commodities

ETFs

IAUI

Seeking Income And Stability? NEOS's Gold High Income ETF May Be Your Answer

Trading Ideas

PHAT

Phathom Pharmaceuticals Shares Halted On Circuit Breaker To The Downside, Stock Now Up 117.1%

Loop Capital analyst Yun Kim maintains Braze (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRZE#NASDAQ">BRZE</a>) with a Buy and lowers the price target from $75 to $45.

BRZE

Loop Capital Maintains Buy on Braze, Lowers Price Target to $45

Phathom Pharmaceuticals Shares Resume Trade

Morgan Stanley analyst Joseph Moore maintains Broadcom (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) with a Overweight and raises the price target from $260 to $270.

AVGO

Morgan Stanley Maintains Overweight on Broadcom, Raises Price Target to $270

<ul>
<li>Nuclear equipment suppliers include Emerson, Westinghouse</li>
<li>Suspensions come amid two-week blitz of restrictions on exports to China</li>
<li>Shipments of hydraulic fluid, jet engines among broad swathe of items affected</li>
<li>Restrictions imposed during tense U.S.-China trade war</li>
</ul>
June 6 (Reuters) - The U.S. in recent days suspended licenses for nuclear equipment suppliers to sell to China's power plants, according to four people familiar with the matter, as the two countries engage in a damaging trade war.
The suspensions were issued by the U.S. Department of Commerce, the people said, and affect export licenses for parts and equipment used with nuclear power plants.
Nuclear equipment suppliers are among a wide range of companies whose <a href="reuters://REALTIME/verb=NewsStory/ric=nS0N3QU081">sales have been restricted</a> over the past two weeks as the U.S.-China trade war shifted from negotiating tariffs to throttling each other's supply chains. It is unclear whether a Thursday call between U.S. President Donald Trump and Chinese President Xi Jinping would affect the suspensions.
The U.S. and China agreed on May 12 to roll back triple digit, tit-for-tat tariffs for 90 days, but the truce between the two biggest economies quickly went south, with the U.S. claiming China reneged on terms related to rare earth elements, and China accusing the U.S. of "abusing export control measures" by warning that using Huawei Ascend AI chips anywhere in the world violated U.S. export controls. After Thursday's call, further talks on key issues were expected.
The U.S. Department of Commerce did not respond to a request for comment on the nuclear equipment restrictions. On May 28, a spokesperson said the department was reviewing exports of strategic significance to China.
"In some cases, Commerce has suspended existing export licenses or imposed additional license requirements while the review is pending," the spokesperson said in a statement. The Chinese Embassy in Washington did not immediately respond to a request for comment.
U.S. nuclear equipment suppliers include Westinghouse and Emerson <a href="https://workspace.refinitiv.com/web/apps/quotewebapi?RIC=EMR.N">EMR.N</a>.
Westinghouse, whose technology is used in over 400 nuclear reactors around the world, and Emerson, which provides measurement and other tools for the nuclear industry, did not respond to requests for comment.
The suspensions affect business worth hundreds of millions of dollars, two of the sources said.
They also coincide with Chinese restrictions on critical metals threatening supply chains for manufacturers worldwide, especially America's Big Three automakers.
Reuters could not determine whether the new restrictions were tied to the trade war, or if and how quickly they might be reinstated. Department of Commerce export licenses typically run for four years and include authorized quantities and values.
But many new restrictions on exports to China have been imposed in the last two weeks, according to sources, and include license requirements for a hydraulic fluids supplier for sales to China.
Other license suspensions went to GE Aerospace for jet engines for China's COMAC aircraft, sources said.
The U.S. also now requires licenses to ship ethane to China, as Reuters reported first last week. Houston-based Enterprise Product Partners <a href="https://workspace.refinitiv.com/web/apps/quotewebapi?RIC=EPD.N">EPD.N</a> said Wednesday that its emergency requests to complete three proposed cargoes of ethane to China, totaling some 2.2 million barrels, had not been granted.
Enterprise said a May 23 requirement for a license to sell butane to China, in addition to the ethane, was subsequently withdrawn. Dallas-based Energy Transfer said it was notified on Tuesday about the new ethane licensing requirement, and planned to apply and file for an emergency authorization.
Other sectors that have been hit with new restrictions include companies that sell electronic design automation software such as Cadence Design Systems <a href="https://workspace.refinitiv.com/web/apps/quotewebapi?RIC=CDNS.O">CDNS.O</a>.

Macro Economic Events

Politics

Global

Economics

General

'U.S. Department Of Commerce Suspends Licenses To Export Nuclear Plant Parts To China, Sources Say' - Reuters Exclusive

Loop Capital analyst Yun Kim maintains ServiceTitan (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTAN#NASDAQ">TTAN</a>) with a Hold and raises the price target from $90 to $100.

TTAN

Loop Capital Maintains Hold on ServiceTitan, Raises Price Target to $100

<ul>
<li>Fed's Harker says rate cuts still possible but outlook uncertain</li>
<li>Harker is worried data critical to economic policy is getting degraded</li>
<li>Harker is set to retire from Philadelphia Fed at month's end</li>
</ul>
June 6 (Reuters) - As he heads toward retirement at month's end, Philadelphia Federal Reserve President Patrick Harker says interest rate cuts remain a possibility this year amid a very uncertain economic landscape, as he also flagged worries about the quality of economic data policymakers use to make their decisions.
When it comes to easing monetary policy, "it's possible, I would never take it off the table," Harker said in an interview with Reuters on Thursday. "If the signals are such that inflation doesn't look like it's moving rapidly north, but unemployment does then, yeah, I could definitely see making one or more cuts this year, but it's hard to say at this point."
Harker was interviewed in the final weeks of his tenure, as he's set to <a href="reuters://REALTIME/verb=NewsStory/ric=nS0N3I404R">retire</a> at the end of June after taking the reins of the Philadelphia Fed in 2015. The Fed next meets on June 17-18 when it is universally expected to hold its interest rate target steady at between 4.25% and 4.5%.
What happens later in the year is up in the air, as the Trump administration's chaotic trade policy featuring ever-changing high import taxes will likely drive up inflation and lower employment. The question facing Fed officials is whether the inflation rise is a one-off or the makings of something more enduring. Those uncertainties have blunted officials' ability to provide guidance on the monetary policy outlook and have pushed them into signaling a wait-and-see attitude.
Harker, an engineer by training who led the University of Delaware before coming to the Fed, said in the interview that he was increasingly worried about the quality of the data policymakers in general rely on.
Data, including that produced by the government, is "not good. It's not getting better," Harker said. "It's not just inflation data but a whole host of data, so we're increasingly flying blind, or at least half blind."
Harker's worries about the state of data come in the wake of reports the government was <a href="reuters://REALTIME/verb=NewsStory/ric=nL2N3S70RP">cutting back on resources</a> devoted to compiling the closely watched consumer price index, which provides a critical reading that informs things like the wage changes in union contracts and the setting of social security benefits.

Federal Reserve

Fed's Harker Says Amid Uncertainty, Still Possible Fed Can Cut Rates Later This Year; Uncertainty Makes It Very Hard To Divine Monetary Policy Outlook; Worries Quality Of Economic Data Is Eroding; 'We're Increasingly Flying Blind' When It Comes To Critical Data; Says 'Very Worried' About Current State Of Government Finance; Deficits Must Be Reined In Amid Rising Challenges To U.S. Financial System; Harker Set To Retire From Philadelphia Fed At Month's End

WIIM

Phathom Pharmaceuticals shares are trading higher after the company announced that the FDA has granted 10-year NCE exclusivity and updated the Orange Book listings for 10 mg and 20 mg Voquezna tablets to reflect full exclusivity through May 3, 2032.

If you've ever wondered when real-life C-3POs or Optimus-style robots might enter your home, or your investment portfolio, KraneShares has a pretty direct answer: right now. 
The asset manager just introduced the KraneShares Global Humanoid and Embodied Intelligence Index ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KOID#NASDAQ">KOID</a>), the first <a href="https://www.benzinga.com/etfs">U.S.-listed ETF</a> to exclusively target the new humanoid robotics universe. 
In simple terms? Your chance to invest in the robots that may eventually take your drive-thru order and put in your solar panels.
Driven by advances in AI, machine learning, smart materials and robotics, humanoid robots are leaving science fiction behind and appearing in real-world factories, hospitals and homes. The ETF follows humanoid form-factor robot and &#8220;embodied intelligence&#8221; companies, essentially intelligent machines that can perceive, learn and act in the physical world.
These aren&#8217;t attitude-paying Roombas. We&#8217;re talking Tesla&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) Optimus, Figure AI and China&#8217;s Unitree, robots with real limbs, facial recognition and in a few instances, enough dexterity to do your laundry.
Also Read: <a href="https://www.benzinga.com/etfs/new-etfs/25/06/45801050/crash-proof-investing-new-innovator-etf-promises-downside-buffer">Crash-Proof Investing? New Innovator ETF Promises Downside Buffer</a>
<h1 class="wp-block-heading">Why Should Investors Care?</h1>
According to Morgan Stanley, the humanoid robotics market could be as high as $5 trillion in revenue per year by the year 2050, with one billion humanoids on the job. That&#8217;s a buffet of opportunity in tech, manufacturing and semiconductors.
&#8220;Soon, the cost of a humanoid robot could be less than a car,&#8221; ventured Derek Yan, CFA, KraneShares Senior Investment Strategist. Which means, robots for the masses, and maybe profits for investors who make an early bet.
Unlike earlier robotics ETFs that bundle in every form of automation under the sun, <a href="https://kraneshares.com/kraneshares-launches-first-global-humanoid-embodied-intelligence-etf-ticker-koid-on-nasdaq/">KOID</a> focuses on the firms directly empowering humanoid robotics and embodied AI. That means:
<ul class="wp-block-list">
<li>Actuation systems (robot muscles)</li>
<li>Sensors and perception technology (how they &#8220;see&#8221; and respond)</li>
<li>Semiconductors &amp; AI chips</li>
</ul>
KOID has international exposure, with U.S., Chinese and Japanese companies covering information tech, industrials and consumer discretionary spaces.
<h1 class="wp-block-heading">Should You Buy?</h1>
If you&#8217;re an investor with a long-term view and an appetite for megatrends, and a willingness to endure a potentially rocky ride to mass humanoid acceptance, KOID might bring a high-risk, high-reward taste to your portfolio.
Diversification and time horizon are as important with all thematic plays. Humanoid robots may not yet take over the globe, but with KOID they could at least occupy a corner of your portfolio.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45804512/trump-musk-feud-gets-ugly-etfs-exposed-with-tesla-caught-in-the-crossfire">Trump-Musk Feud Gets Ugly: ETFs Exposed With Tesla Caught In The Crossfire</a></li>
</ul>
Photo: Around the World Photos via Shutterstock

KOID

TSLA

KOID ETF: Your Gateway To The $5 Trillion Humanoid Robotics Market

U.S. stocks traded higher midway through trading, with the Nasdaq Composite jumping more than 1% on Friday.
The Dow traded up 1.05% to 42,765.32 while the NASDAQ gained 1.31% to 19,551.81. The S&amp;P 500 also rose, gaining, 1.10% to 6,004.74.
Check This Out: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/06/45811726/cramer-says-hes-not-going-to-really-want-to-do-a-lot-of-china-right-now">Cramer Says He&#8217;s &#8216;Not Going To Really Want To Do A Lot Of China Right Now&#8217;</a>
Leading and Lagging Sectors Energy shares jumped by 2% on Friday.
In trading on Friday, utilities stocks fell by 0.2%.
Top Headline
Shares of ABM Industries Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABM#NYSE">ABM</a>) fell more than 13% on Friday after the company reported results for the second quarter.
Revenue grew 4.6% year over year (Y/Y) to $2.11 billion, beating the consensus of $2.06 billion. This was led by organic growth of 3.8% and a 0.8% contribution from acquisitions. Adjusted EPS of 86 cents was in line with the consensus.
For FY25, ABM reiterated the adjusted EPS outlook at $3.65 to $3.80 versus the consensus of $3.77. The company continues to see an adjusted EBITDA margin of 6.3%- 6.5%.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul class="wp-block-list">
<li>Quanex Building Products Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NX#NYSE">NX</a>) shares shot up 20% to $20.52 after the company reported better-than-expected second-quarter financial results.</li>
<li>Shares of Davis Commodities Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTCK#NASDAQ">DTCK</a>) got a boost, surging 50% to $0.9018 after the company announced approval of $30 million fundraising plan to establish Bitcoin reserves to strengthen asset allocation.</li>
<li>Venus Concept Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERO#NASDAQ">VERO</a>) shares were also up, gaining 17% to $2.80 after the company announced it entered into a definitive agreement to sell its Venus Hair business to Meta Healthcare Group.</li>
</ul>
Equities Trading DOWN
<ul class="wp-block-list">
<li>Vera Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERA#NASDAQ">VERA</a>) shares dropped 29% to $21.73.</li>
<li>Shares of lululemon athletica inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) were down 20% to $263.96 after the company reported first-quarter financial results and issued its second-quarter GAAP EPS results below estimates. Also, the company cut its FY25 GAAP EPS guidance below estimates.</li>
<li>DocuSign, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DOCU#NASDAQ">DOCU</a>) was down, falling 18% to $75.79 following first-quarter results.</li>
</ul>
Commodities In commodity news, oil traded up 2% to $64.65 while gold traded down 0.6% at $3,355.20.
Silver traded up 1.2% to $36.22 on Friday, while copper fell 0.9% to $4.8885.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 rose 0.32%, while Spain's IBEX 35 Index rose 0.31%. London's FTSE 100 rose 0.30%, Germany's DAX 40 fell 0.08% and France's CAC 40 rose 0.19% during the session.
Asia Pacific Markets
Asian markets closed mostly higher on Friday, with Japan's Nikkei gaining 0.50%, Hong Kong's Hang Seng Index falling 0.48%, China's Shanghai Composite gaining 0.04% and India's BSE Sensex gaining 0.92%.
Economics
<ul class="wp-block-list">
<li>Nonfarm payrolls rose by 139,000 in May, beating consensus expectations of 130,000, according to data released Friday by the Bureau of Labor Statistics.</li>
<li>Average hourly earnings rose 0.4% in May, the strongest monthly increase since January and ahead of the expected 0.3%.</li>
<li>The US unemployment rate came in steady at 4.2% for May.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/45813240/top-2-energy-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Energy Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Earnings

Eurozone

Markets

DTCK

LULU

VERA

VERO

Crude Oil Gains 2%; ABM Industries Shares Plunge After Q2 Results

Phathom Pharmaceuticals Shares Resume Trade Then Again Halt On Circuit Breaker To The Upside, Stock Now Up 127.5%

Laidlaw &amp; Co. analyst Yale Jen initiates coverage on Senti Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNTI#NASDAQ">SNTI</a>) with a Buy rating and announces Price Target of $15.

Initiation

SNTI

Laidlaw & Co. Initiates Coverage On Senti Biosciences with Buy Rating, Announces Price Target of $15

GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>) has outperformed the market over the past 5 years by 31.72% on an annualized basis producing an average annual return of 45.01%. Currently, GE Aerospace has a market capitalization of $273.04 billion. 
Buying $100 In GE: If an investor had bought $100 of GE stock 5 years ago, it would be worth $607.88 today based on a price of $256.04 for GE at the time of writing.
<h3>GE Aerospace's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749226514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In GE Aerospace 5 Years Ago Would Be Worth This Much Today

- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis -
- Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA&#xAE; –
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vrtx.com%2F&amp;esheet=54266897&amp;newsitemid=20250606362203&amp;lan=en-US&amp;anchor=Vertex+Pharmaceuticals+Incorporated&amp;index=1&amp;md5=eb77f3c67389e9e5a8a914fa1115154c">Vertex Pharmaceuticals Incorporated</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK&#xAE; (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year's European Cystic Fibrosis Society's (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy.
During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit including better and more stable lung function, fewer pulmonary exacerbations, better nutritional status and better quality of life. SwCl levels below 30 mmol/L generally demonstrated greater numerical benefit than all other groups, with confidence intervals that overlapped with the ≥30 to &lt;60 mmol/L group.
Vertex also presented the results of a post hoc analysis from the Phase 3 randomized, controlled and open-label trials of ALYFTREK (abstract WS19.04) which suggest treatment with ALYFTREK is associated with improved health-related quality of life outcomes in adolescents and adults, and with improved CF symptoms and general functioning in children aged 6-11 years compared to patients treated with TRIKAFTA.

VRTX

Vertex Pharma Showcases ALYFTREK's Clinical And Quality Of Life Benefits At European Cystic Fibrosis Conference

Contracts

Press Releases

EuroDry Ltd. Signs Contract for the Construction of Two Modern 63,500 DWT Ultramax Bulk Carriers

UPDATE – Capital Link Shipping Sectors Webinar Series - December 2024 - Dry Bulk, Container, Product Tanker, Crude Tanker, LPG, LNG Shipping

Shipping: State of Play & What Lies Ahead

EuroDry Ltd. Announces Agreement to Sell M/V Tasos, a 2000-built Panamax Bulk Carrier

EuroDry Ltd. Sets Date for the Release of Fourth Quarter 2024 Results, Conference Call and Webcast

EuroDry Ltd. Reports Results for the Year and Quarter Ended December 31, 2024

Industry Leaders Presenting at Capital Link's 19th Annual International Shipping Forum - Monday March 31, 2025, New York City

Insights from Industry Leaders: Capital Link's Quarterly Shipping Report – Q1 2025

EuroDry Ltd. Sets Date for the Release of First Quarter 2025 Results, Conference Call and Webcast

EuroDry Ltd. Reports Results for the Quarter Ended March 31, 2025

BWLP

CCEC

CDLR

CLCO

DMCOF

EDRY

ESEA

FLNG

GOGL

HAFN

INSW

NVGS

PANL

SBLK

SHIP

STNG

SVCCU

USEA

Capital Clean Energy Carriers Corp. - Common Share

Capital Clean Energy

Costamare Bulkers Holdings Limited Common Stock

Costamare Bulkers Hldgs

Costamare Inc. Common Stock $0.0001 par value

Costamare

Castor Maritime

Danaos

Diana Shipping

Euroseas

Globus Maritime

Genco Shipping & Trading Limited Ordinary Shares New (Marshall Islands)

Genco Shipping & Trading

Golden Ocean Group Limited - Common Stock

Golden Ocean Group

Global Ship Lease Inc New Class A Common Shares

Global Ship Lease

Himalaya Shipping

High-Trend International Group - Class A Ordinary Shares

High-Trend International

Kirby

Matson

Intercont (Cayman) Limited - Ordinary shares

Intercont (Cayman)

Navios Maritime Partners LP Common Units Representing Limited Partner Interests

Navios Maritime Partners

Pangaea Logistics Solutions Ltd. - Common Stock

Pangaea Logistics Solns

Performance Shipping Inc. - Common Shares

Performance Shipping

Pyxis Tankers

Safe Bulkers, Inc Common Stock ($0.001 par value)

Safe Bulkers

Star Bulk Carriers

Seanergy Maritime Holdings Corp. - Common Stock

Seanergy Maritime Hldgs

Toro

ZIM Integrated Shipping Services Ltd. Ordinary Shares

Comments

EuroDry

EuroDry (EDRY) 옵션

No option chain data available. Please try again later

뉴스

파트너 / 기고자

벤징가 글로벌